Can I Take Melatonin with Egrifta (Tesamorelin)?
At a glance
- Interaction with melatonin listed in the Egrifta labels / No; melatonin is not named [1][2]
- Egrifta interaction sections cover / CYP450-metabolized drugs and glucocorticoids [1][2]
- Tesamorelin and glucose / HbA1c 6.5% or higher in 5% vs 1% on placebo [1]
- Melatonin regulatory status / Dietary supplement, not an FDA-approved drug [3][4]
- Gummy products mislabeled in testing / 22 of 25 [4]
- Melatonin vs placebo, sleep latency / 7.06 minutes faster across 19 trials [5]
Is melatonin listed as an interaction with Egrifta?
The drug interactions section of the Egrifta SV label covers two categories: other medicines metabolized by CYP450 liver enzymes, and glucocorticoid replacement such as prednisone or cortisone acetate [1]. The Egrifta WR label is worded the same way [2]. Melatonin is not among the drugs named in either.
The label says growth hormone may change the clearance of compounds metabolized by CYP450 liver enzymes, naming corticosteroids, sex steroids, anticonvulsants and cyclosporine as examples, and tells prescribers to monitor for that [1].
Separately, melatonin exposure is sensitive to some other drugs. In one small study, five healthy men took 5 mg of oral melatonin with and without 50 mg of fluvoxamine. Melatonin exposure (AUC) rose about 17-fold and peak concentration about 12-fold [6]. This study did not involve tesamorelin.
What the Egrifta label says about glucose
Tesamorelin stimulates the pituitary to release growth hormone. The Egrifta label warns that treatment can cause glucose intolerance or diabetes [1]. In the trials, HbA1c of 6.5% or higher developed in 5% of tesamorelin-treated patients versus 1% on placebo by week 26, a hazard ratio of about 3.3 (95% CI 1.4 to 9.6) [1]. Those trials excluded people with type 1 or type 2 diabetes at entry [1].
The label asks prescribers to evaluate glucose status before starting Egrifta SV and to monitor patients periodically during treatment. It also asks for regular checks for development or worsening of retinopathy in people with diabetes [1]. It says to consider stopping tesamorelin in patients who develop glucose intolerance or diabetes and do not show a clear efficacy response [1].
Questions worth asking
Melatonin's own side effects
NCCIH says short-term melatonin use appears safe for most people. Reported mild side effects include headache, dizziness, nausea and sleepiness, and long-term safety information is lacking [7].
A systematic review of 79 randomized trials of 10 mg or more of melatonin in adults (3,861 participants) found that only four trials met low-risk-of-bias criteria. In those four, melatonin showed no detectable increase in serious adverse events (rate ratio 0.88, 95% CI 0.52 to 1.50) but more drowsiness, headache and dizziness (rate ratio 1.40, 95% CI 1.15 to 1.69). The authors describe the evidence as limited [8].
What you actually get in a melatonin product
In the US, melatonin is sold as a dietary supplement, not an FDA-approved drug [3][4]. In a 2023 JAMA analysis of 25 melatonin gummy products, 22 (88%) were inaccurately labeled and only 3 were within 10% of the declared amount. Among the 24 that contained melatonin, measured content ranged from 74% to 347% of the label. Measured melatonin per serving ranged from 1.3 mg (labeled 1.0 mg) to 13.1 mg (labeled 10 mg) [4]. Five products declared CBD, and one product labeled as 5 mg melatonin with 30 mg CBD contained no detectable melatonin [4]. An earlier analysis of 31 supplements found melatonin content from 83% below to 478% above the labeled amount, and serotonin in 8 of them at 1 to 75 micrograms [9].
Does melatonin work for sleep?
Modestly, on average. A 2013 meta-analysis of 19 randomized placebo-controlled trials in 1,683 adults and children with primary sleep disorders found melatonin shortened sleep latency by 7.06 minutes (95% CI 4.37 to 9.75) and increased total sleep time by 8.25 minutes (95% CI 1.74 to 14.75) [5]. A 2022 meta-analysis of 24 trials in chronic insomnia found melatonin was not significantly effective for sleep onset latency, total sleep time or sleep efficiency in adults without comorbid insomnia [10].
The American Academy of Sleep Medicine's 2017 guideline suggests clinicians not use melatonin to treat sleep-onset or sleep-maintenance insomnia in adults, a weak recommendation [11].
Other melatonin cautions
NCCIH says people with epilepsy and people taking blood thinner medications need to be under medical supervision if they use melatonin [7]. That is a general caution about melatonin, not one specific to tesamorelin.
Frequently asked questions
Can I take melatonin while using Egrifta?
Can other drugs change how much melatonin I absorb?
Is there a set melatonin dose to use with Egrifta?
Will melatonin blunt Egrifta's fat loss?
How well does melatonin work for sleep?
Is long-term melatonin use a concern?
References
Show all 11 referencesHide references
- U.S. National Library of Medicine, DailyMed. Egrifta SV (tesamorelin) for injection, 2 mg vial prescribing information. Egrifta SV (tesamorelin) for injection, 2 mg vial label
- U.S. National Library of Medicine, DailyMed. Egrifta WR (tesamorelin) for injection, 11.6 mg vial prescribing information. Egrifta WR (tesamorelin) for injection, 11.6 mg vial label
- Lelak K, Vohra V, Neuman MI, Toce MS, Sethuraman U. Pediatric Melatonin Ingestions - United States, 2012-2021. MMWR Morb Mortal Wkly Rep. 2022;71(22):725-729.
- Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US - PMC.
- Ferracioli-Oda E, Qawasmi A, Bloch MH. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8(5):e63773.
- Härtter S, Grözinger M, Weigmann H, Röschke J, Hiemke C. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther. 2000;67(1):1-6.
- Melatonin: What You Need To Know | NCCIH.
- Menczel Schrire Z, Phillips CL, Chapman JL, Duffy SL, Wong G, D'Rozario AL, et al. Safety of higher doses of melatonin in adults: A systematic review and meta-analysis. J Pineal Res. 2022;72(2):e12782.
- Erland LA, Saxena PK. Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content. J Clin Sleep Med. 2017;13(2):275-281.
- Choi K, Lee YJ, Park S, Je NK, Suh HS. Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses. Sleep Med Rev. 2022;66:101692.
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307-349.